Impaired Arachidonic Acid–Mediated Activation of Large-Conductance Ca2+-Activated K+ Channels in Coronary Arterial Smooth Muscle Cells in Zucker Diabetic Fatty Rats
- Tong Lu1,
- Xiao-Li Wang1,
- Tongrong He2,
- Wei Zhou1,
- Terry L. Kaduce3,
- Zvonimir S. Katusic2,
- Arthur A. Spector3 and
- Hon-Chi Lee1
- 1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
- 2Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota
- 3Department of Biochemistry, University of Iowa, Iowa City, Iowa
- Address correspondence and reprint requests to Tong Lu, MD, PhD, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First St., SW, Rochester, MN 55905. E-mail: lu.tong{at}mayo.edu
Abstract
We studied the arachidonic acid (AA)-mediated modulation of large-conductance Ca2+-activated K+ (BK) channels in coronary arterial smooth myocytes from lean control and Zucker Diabetic Fatty (ZDF) rats. A total of 1 μmol/l AA enhanced BK current by 274% in lean and by 98% in ZDF rats. After incubation with 10 μmol/l indomethacin, 1 μmol/l AA increased BK currents by 80% in lean and by 70% in ZDF rats. Vasoreactivity studies showed that the dilation of small coronary arteries produced by 1 μmol/l AA was reduced by 44% in ZDF rats. [3H]6-keto-prostagladin F1α ([3H]6-keto-PGF1α,), the stable metabolite of prostacyclin (PGI2), was the major [3H]AA metabolite produced by coronary arteries of lean vessels, but ZDF vessels produced only 15% as much [3H]6-keto-PGF1α. BK channel activation and vasorelaxation by iloprost were similar in lean and ZDF rats. Immunoblots showed a 73% reduction in PGI2 synthase (PGIS) expression in ZDF vessels compared with lean vessels, and there was no change in cyclooxygenase (COX) and BK channel expressions. Real-time PCR studies showed that mRNA levels of PGIS, COX-1, and COX-2 were similar between lean and ZDF vessels. We conclude that PGI2 is the major AA metabolite in lean coronaries, and AA-mediated BK channel activation is impaired in ZDF coronaries due to reduced PGIS activity.
- 6-keto-PGF1α, 6-keto-prostagladin F1α
- 12-HETE, 12-hydroxyeicosatetraenoic acid
- AA, arachidonic acid
- BK, large-conductance Ca2+-activated K+
- COX, cyclooxygenase
- CYP, cytochrome P450
- DMEM, Dulbecco’s modified Eagle’s medium
- IBTX, iberiotoxin
- IP, PGI2 receptor
- LOX, lipoxygenase
- PGI2, prostacyclin
- PGIS, PGI2 synthase
Footnotes
-
- Accepted March 23, 2005.
- Received August 14, 2004.
- DIABETES














